€71.20
0.00%
Xetra, Wed, Nov 26 2025
ISIN
DE0005220909
Symbol
NXU
Index

New AI Insights on NEXUS Insights AI Insights on NEXUS

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
€135.7m
Shares outstanding
17.3m
Valuation (TTM | estimate)
P/E
- | -
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
€0.23
Yield 1Y | 5Y
0.3% | 0.4%
Growth 1Y | 5Y
4.5% | 5.0%
Payout 1Y | 3Y
12.9% | 15.0%
Increased
14 Years
Financials (TTM | estimate)
Revenue
€280.3m | €296.8m
EBITDA
€62.9m | €65.5m
EBIT
€43.2m | €45.4m
Net Income
€34.0m | €33.1m
Free Cash Flow
€56.5m
Growth (TTM | estimate)
Revenue
7.4% | 13.5%
EBITDA
11.9% | 13.5%
EBIT
16.2% | 17.2%
Net Income
26.9% | 7.3%
Free Cash Flow
168.4%
Margin (TTM | estimate)
Gross
84.7%
EBITDA
22.5% | 22.1%
EBIT
15.4%
Net
12.1% | 11.1%
Free Cash Flow
20.2%
Financial Health
Equity Ratio
63.8%
Return on Equity
11.0%
ROCE
11.1%
ROIC
11.9%
Debt/Equity
0.1
More
EPS
€2.0
FCF per Share
€3.3
Short interest
-
Employees
2k
Rev per Employee
€140.0k
Show more

Is NEXUS a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

NEXUS Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a NEXUS forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a NEXUS forecast:

Hold
43%
Sell
57%

Financial data from NEXUS

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
280 280
7% 7%
100%
- Direct Costs 43 43
10% 10%
15%
237 237
7% 7%
85%
- Selling and Administrative Expenses 155 155
6% 6%
55%
- Research and Development Expense - -
-
-
63 63
12% 12%
22%
- Depreciation and Amortization 20 20
3% 3%
7%
EBIT (Operating Income) EBIT 43 43
16% 16%
15%
Net Profit 34 34
27% 27%
12%

In millions EUR.

Don't miss a Thing! We will send you all news about NEXUS directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NEXUS AG engages in the development and sale of software and hardware solutions. It operates its business through the Healthcare Software and Healthcare Services segments. The Healthcare Software segment provides software products on information systems for hospital and psychiatric, rehabilitation, and welfare institutions. The Healthcare Services offers information technology outsourcing services for institutions in the healthcare system. The company is headquartered in Donaueschingen, Germany.

Head office Germany
CEO Ingo Behrendt
Employees 1,909
Founded 1999
Website www.nexus-ag.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today